Antidepressant drug use & the risk of suicide

@article{Healy2005AntidepressantDU,
  title={Antidepressant drug use \& the risk of suicide},
  author={D. Healy and Graham Aldred},
  journal={International Review of Psychiatry},
  year={2005},
  volume={17},
  pages={163 - 172}
}
There have been longstanding concerns about the propensity of antidepressants to precipitate suicidality in vulnerable individuals. To investigate this further, first we have analyzed all clinical trials, and in particular trials submitted to regulators for evidence on the relative risk of antidepressants versus placebo for this hazard. Second, we have compiled current epidemiological evidence germane to the issue. Third, we have constructed a model (Investigative Medication Routine; IMR) to… Expand
Overuse of Antidepressant Drugs for the Treatment of Depression
TLDR
Unless prescribing patterns change, any benefits from increasing access to antidepressants for those with severe depression will be accompanied by significant harms due to inappropriate prescribing in conditions, such as mild depression, where antidepressants are not indicated. Expand
Are Selective Serotonin Reuptake Inhibitors a Risk Factor for Adolescent Suicide?
  • D. Healy
  • Medicine
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2009
TLDR
A series of articles have shown suicidal act rates falling in depressed patients after the institution of treatment, and there have been suggestions of increased pediatric suicide rates in the United States and Holland since warnings were placed on antidepressants, although these uncontrolled studies may demonstrate little more. Expand
Sales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: an ecological study
TLDR
It is possible that the increase in antidepressant prescribing might be associated with earlier treatment of depression, thus decreasing the likelihood of aggravation of depression. Expand
Ten years after the FDA black box warning for antidepressant drugs: a critical narrative review
Background The United States Food and Drug Administration (FDA) has warned about the increased suicidality risk associated with the use of selective serotonin reuptake inhibitors (SSRI) andExpand
National Suicide Rates 1961–2003: Further Analysis of Nordic Data for Suicide, Autopsies and Ill-Defined Death Rates
TLDR
There is a close correlation between suicide rates and both autopsy and ill-defined death rates in the Nordic countries and the role of autopsies and other factors in the registration of a death as a suicide appear to need further clarification. Expand
Predictors of start of different antidepressants in patient charts among patients with depression.
TLDR
To identify factors recorded in electronic medical chart progress notes predictive of antidepressant selection among patients who had received a depression diagnosis, a retrospective study of 556 randomly selected Veterans Health Administration patients diagnosed with depression found some chart data-based variables were predictive of antidepressants selection, but not many nor found them highly predictive. Expand
Antidepressants and lethal violence in the Netherlands
TLDR
Dear Editor, Bouvy and Liem’s article correlating antidepressant usage and violence in the Netherlands offers a good example of the hazards of making inferences from broad-brush epidemiological data, and makes selective use of evidence linking antidepressants to suicide and violence. Expand
Integrated risk assessment of suicidal ideation and behavior in drug development.
TLDR
An industry consensus framework for risk assessment and decision making of SIB during drug development is presented based on chemical and pharmacological similarities of compounds with clinical evidence of suicidal intent, target or indication classes associated with high incidence of S IB. Expand
Suicidality in Huntington's disease.
TLDR
The presence of a depressed mood is both associated with and predictive of suicidality in HD and assessment of depressed mood can help to identify individuals with increased risk for suicide. Expand
Antidepressant Prescribing and Suicides in Emilia-Romagna Region (Italy) from 1999 to 2008: An Ecological Study
  • G. Guaiana
  • Medicine
  • Clinical practice and epidemiology in mental health : CP & EMH
  • 2011
TLDR
The overall suicide rates decreased during the period under examination, in spite of the observed exponential increase in use of ADs. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 30 REFERENCES
Antidepressants and suicide: what is the balance of benefit and harm
TLDR
Although antidepressant prescribing in Britain has more than doubled in the past 15 years, population suicide rates have fallen and long term studies are required to assess the risks and benefits to population health of recent large scale rises. Expand
Antidepressants and suicide: risk-benefit conundrums.
TLDR
The data reviewed here make it difficult to sustain a null hypothesis that SSRIs do not cause problems in some individuals and further studies or further access to data are indicated to establish the magnitude of any risk and the characteristics of patients who may be most at risk. Expand
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.
TLDR
Suicide risk and symptom reduction among placebo-treated patients participating in antidepressant clinical trials for two recently approved antidepressants, venlafaxine ER and citalopram, which were unavailable during the previous study are assessed. Expand
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.
TLDR
Assessment of suicides, suicide attempts, and depressive symptom reduction in studies of 7 new antidepressants using the Food and Drug Administration database may help inform discussions about the use of placebo in antidepressant clinical trials. Expand
Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.
TLDR
Findings fail to support either an overall difference in suicide risk between antidepressant- and placebo-treated depressed subjects in controlled trials or a difference between SSRIs and either other types of antidepressants or placebo. Expand
Suicide risk in placebo-controlled studies of major depression.
TLDR
Fear of increased risk of attempted suicide in the placebo groups should not be an argument against performing short-term and long-term, placebo-controlled trials in major depression. Expand
Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.
TLDR
Age, gender and pre-existing depression/suicidal ideation are important confounders in observational studies of the association between antidepressants and suicide or self harm. Expand
Antidepressants and suicide
TLDR
Several factors correlate with the risk of suicide in people taking antidepressants, and rates of suicide were higher in patients who received fluoxetine, but this may be explained by selection biases which were present for those drug users. Expand
Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts
TLDR
Fluoxetine neither raised nor lowered the suicide attempt rate as compared with placebo, providing no evidence to support the drug's role in either suicide provocation or prevention. Expand
Modelling suicide risk in affective disorders
TLDR
Lifetime prevalence rates of suicide in subgroups of affective disorders may be lower than the traditional rates cited for hospital depression, which has implications for primary care projects designed to investigate the occurrence of and the prevention of suicide. Expand
...
1
2
3
...